Concise Analysis of the International Stem Cell Markets

DUBLIN, Ireland, February 3, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/2c2thn/stem_cell_markets) has announced the addition of the "Concise Analysis of the International Stem Cell Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells.

Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential.

The purpose of this report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently in use today for preparing and using stem cells. It examines the use of stem cells in developing new therapies for disease.

Key Topics Covered:

1. Overview

2. Biology of Stem Cells

3. Stem Cell Therapy

4. Market Analysis of the Stem Cell Space

5. Strategic Roadmap to Cell Therapy Industry

6. Funding for Regenerative Medicine Research

7. Current Stem Cell Research

8. Company Profiles

Companies Mentioned:

• Aastrom Biosciences, Inc
• Advanced Cell Technology, Inc
• Aldagen, Inc
• Alseres Pharmaceuticals, Inc
• Amgen, Inc
• Amorcyte, Inc
• Angioblast Systems, Inc
• Asterand plc
• Athersys, Inc
• BD Biosciences
• BioE, Inc
• BioMimetic Therapeutics, Inc
• Bioheart, Inc
• Biosafe Group SA
• Brainstorm Cell Therapeutics, Inc
• Cardio3 BioSciences
• ES Cell International Pvt, Ltd
• Forticell Bioscience, Inc
• Gamida Cell
• GenVec, Inc
• Geron Corporation
• Glycosan Biosystems, Inc
• Humacyte, Inc
• Integra LifeSciences Holding, Corp
• Intercytex Group plc
• International Stem Cell Corporation
• Japan Tissue Engineering Co., Ltd
• Life Technologies Corporation
• LifebankUSA
• Lonza
• MedCell Bioscience, Ltd
• Medistem, Inc
• Mesoblast Limited
• Millipore Corporation
• Miltenyi Biotec
• Neostem, Inc
• NeuralStem, Inc
• NeuroGeneration
• Novocell, Inc
• Opexa Therapeutics, Inc
• OrCel®
• Organogenesis, Inc
• Orthovita, Inc
• Osiris Therapeutics, Inc
• Pervasis Therapeutics, Inc
• Pleuron Corp
• Pluristem Therapeutics, Inc
• ReNeuron Group Plc
• Regenocyte Therapeutic
• Reinnervate LLC
• Saneron Therapeutics, Inc
• Scikon Innovation, Inc
• Stem Cell Sciences KK
• Stem Cell Therapy International, Inc
• Stem Cells, Inc
• StemCell Technologies, Inc
• Stempeutics Research Private Limited
• Tengion, Inc
• TheraVitae
• VistaGen Therapeutics, Inc
• ZenBio, Inc

For more information visit http://www.researchandmarkets.com/research/2c2thn/stem_cell_markets

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets